Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth

Published:2006-09-22 Issue:1 Volume:14 Page:19-29
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Cordelier P,Bienvenu C,Lulka H,Marrache F,Bouisson M,Openheim A,Strayer D S,Vaysse N,Pradayrol L,Buscail L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700987.pdf

Reference71 articles.

1. Safioleas MC, Moulakakis KG . Pancreatic cancer today. Hepatogastroenterology 2004; 51: 862–868.

2. Jemal A, Thomas A, Murray T, Thun M . Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23–47.

3. Rosewicz S, Wiedenmann B . Pancreatic carcinoma. Lancet 1997; 349: 485–489.

4. Jafari M, Abbruzzese JL, Goldstein D, Carroll S, Apte M, Keogh G . Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force Modern management of pancreatic carcinoma. Surg Oncol Clin N Am 2004; 13: 751–760.

5. Kulke MH . Metastatic pancreatic cancer. Curr Treat Options Oncol 2002; 3: 449–457.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer;Molecular Therapy - Methods & Clinical Development;2023-06

2. Gene Therapy Cargoes Based on Viral Vector Delivery;Current Gene Therapy;2023-04

3. Viral Vectors in Gene Therapy: Where Do We Stand in 2023?;Viruses;2023-03-07

4. Viral vectors engineered for gene therapy;Viral Vectors in Cancer Immunotherapy;2023

5. Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer;2022-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3